OI
BSX icon

Oakbrook Investments’s Boston Scientific BSX Stock Holding History

Oakbrook Investments’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$256K Sell
7,850
-20,225
-72% -$790K 0.65% 56
2019
Q4 		$1.27M Sell
28,075
-55,900
-67% -$2.34M 0.26% 78
2019
Q3 		$3.42M Sell
83,975
-15,650
-16% -$663K 0.22% 67
2019
Q2 		$4.28M Buy
99,625
+20,050
+25% +$771K 0.26% 67
2019
Q1 		$3.05M Sell
79,575
-13,950
-15% -$533K 0.19% 91
2018
Q4 		$3.31M Buy
93,525
+14,100
+18% +$511K 0.22% 73
2018
Q3 		$3.06M Sell
79,425
-1,900
-2% -$66.4K 0.17% 99
2018
Q2 		$2.66M Sell
81,325
-10,235
-11% -$309K 0.17% 97
2018
Q1 		$2.5M Buy
91,560
+5,100
+6% +$139K 0.16% 107
2017
Q4 		$2.14M Sell
86,460
-10,140
-10% -$280K 0.14% 114
2017
Q3 		$2.82M Buy
96,600
+4,150
+4% +$115K 0.18% 99
2017
Q2 		$2.56M Sell
92,450
-11,850
-11% -$314K 0.17% 109
2017
Q1 		$2.59M Sell
104,300
-1,650
-2% -$40.1K 0.17% 109
2016
Q4 		$2.29M Sell
105,950
-17,400
-14% -$380K 0.15% 123
2016
Q3 		$2.94M Buy
123,350
+44,150
+56% +$1.05M 0.18% 107
2016
Q2 		$1.85M Sell
79,200
-63,799
-45% -$1.38M 0.1% 171
2016
Q1 		$2.69M Sell
142,999
-300
-0.2% -$5.27K 0.17% 113
2015
Q4 		$2.64M Sell
143,299
-26,400
-16% -$473K 0.17% 111
2015
Q3 		$2.79M Sell
169,699
-3,000
-2% -$51.3K 0.18% 115
2015
Q2 		$3.06M Sell
172,699
-21,900
-11% -$391K 0.19% 117
2015
Q1 		$3.45M Buy
194,599
+31,750
+19% +$502K 0.19% 127
2014
Q4 		$2.16M Sell
162,849
-5,900
-3% -$75.4K 0.12% 166
2014
Q3 		$1.99M Sell
168,749
-227,500
-57% -$2.86M 0.11% 181
2014
Q2 		$5.06M Sell
396,249
-21,700
-5% -$282K 0.15% 155
2014
Q1 		$5.65M Sell
417,949
-43,534
-9% -$571K 0.18% 134
2013
Q4 		$5.55M Sell
461,483
-23,700
-5% -$280K 0.15% 155
2013
Q3 		$5.7M Sell
485,183
-23,500
-5% -$254K 0.17% 144
2013
Q2 		$4.71M Buy
+508,683
New +$4.31M 0.14% 169

Other funds holding BSX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

Oakbrook Investments's BSX Position: Q1 2020 in Review

Oakbrook Investments reduced its Boston Scientific (BSX) stake by 72% in Q1 2020, selling an estimated $790K and leaving 7,850 shares worth $256K. The position accounts for 0.65% of the portfolio, ranked #56.

Oakbrook Investments first reported a position in BSX in Q2 2013 and has held it in 28 quarters since. The position peaked at $5.7M in Q3 2013. 801 funds tracked by Wall St. Rank hold BSX as of Q1 2020.

  • Oakbrook Investments held 7,850 shares of Boston Scientific worth $256K as of Q1 2020.
  • Oakbrook Investments sold 20,225 Boston Scientific shares in Q1 2020, an estimated $790K.
  • Boston Scientific made up 0.65% of Oakbrook Investments's portfolio in Q1 2020, its #56 holding.
  • Oakbrook Investments first reported a position in Boston Scientific in Q2 2013 and has held it in 28 quarters since.
  • Oakbrook Investments's Boston Scientific position peaked at $5.7M in Q3 2013.
  • 801 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2020.

Based on Oakbrook Investments's 13F filing for Q1 2020, filed 22 Apr 2020.